468 related articles for article (PubMed ID: 29160859)
1. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic variants of RNF213 with ischemic stroke risk in Koreans.
Park YS; Park HW; Park HS; Ryu CS; Lee JY; Ko EJ; Sung JH; Kim J; Kim OJ; Kim NK
Genes Genomics; 2021 Apr; 43(4):389-397. PubMed ID: 33609224
[TBL] [Abstract][Full Text] [Related]
3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
4. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Intracranial Major Artery Stenosis/Occlusion According to RNF213 Polymorphisms.
Kim J; Park YS; Woo MH; An HJ; Kim JO; Park HS; Ryu CS; Kim OJ; Kim NK
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32182997
[TBL] [Abstract][Full Text] [Related]
6. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
7. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
8. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
Huang Y; Cheng D; Zhang J; Zhao W
J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
[TBL] [Abstract][Full Text] [Related]
9. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
11. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
[TBL] [Abstract][Full Text] [Related]
12. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
13. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
14. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G
Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926
[TBL] [Abstract][Full Text] [Related]
15. The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.
Sun XS; Wen J; Li JX; Lai R; Wang YF; Liu HJ; Sheng WL
Mol Genet Genomics; 2016 Jun; 291(3):1193-203. PubMed ID: 26847828
[TBL] [Abstract][Full Text] [Related]
16. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
17. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.
Kamada F; Aoki Y; Narisawa A; Abe Y; Komatsuzaki S; Kikuchi A; Kanno J; Niihori T; Ono M; Ishii N; Owada Y; Fujimura M; Mashimo Y; Suzuki Y; Hata A; Tsuchiya S; Tominaga T; Matsubara Y; Kure S
J Hum Genet; 2011 Jan; 56(1):34-40. PubMed ID: 21048783
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
[TBL] [Abstract][Full Text] [Related]
20. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]